Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.
To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with tacrolimus
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Yang J et al. | Zinc finger protein A20 protects rats against chronic liver allograft dysfunction. | 2012 | World J. Gastroenterol. | pmid:22826618 |
Chen ZS et al. | Early steroid withdrawal after liver transplantation for hepatocellular carcinoma. | 2007 | World J. Gastroenterol. | pmid:17876900 |
Li DW et al. | Risk factors for new onset diabetes mellitus after liver transplantation: A meta-analysis. | 2015 | World J. Gastroenterol. | pmid:26034369 |
Liu F et al. | Tacrolimus dosage requirements in living donor liver transplant recipients with small-for-size grafts. | 2009 | World J. Gastroenterol. | pmid:19701975 |
Jiang JW et al. | Optimal immunosuppressor induces stable gut microbiota after liver transplantation. | 2018 | World J. Gastroenterol. | pmid:30228781 |
Indriolo A and Ravelli P | Clinical management of inflammatory bowel disease in the organ recipient. | 2014 | World J. Gastroenterol. | pmid:24707135 |
Shen T et al. | Reversible sinusoidal obstruction syndrome associated with tacrolimus following liver transplantation. | 2015 | World J. Gastroenterol. | pmid:26034381 |
Kiyama T et al. | Tacrolimus enhances colon anastomotic healing in rats. | 2002 Sep-Oct | Wound Repair Regen | pmid:12406167 |
Gupta AS et al. | Pyoderma Gangrenosum of the Scalp: A Rare Clinical Variant. | 2018 | Wounds | pmid:29481333 |
Zhou YN et al. | Effect of amlodipine on the pharmacokinetics of tacrolimus in rats. | 2013 | Xenobiotica | pmid:23312000 |
Picard N | The pharmacokinetic interaction between mycophenolic acid and cyclosporine revisited: a commentary on "Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus". | 2013 | Xenobiotica | pmid:23339626 |
Fujiyama N et al. | Influence of carboxylesterase 2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients. | 2009 | Xenobiotica | pmid:19274604 |
Tata PN et al. | Species-dependent hepatic metabolism of immunosuppressive agent tacrolimus (FK-506). | 2009 | Xenobiotica | pmid:19604035 |
Zhang S et al. | Effect of voriconazole and other azole antifungal agents on CYP3A activity and metabolism of tacrolimus in human liver microsomes. | 2012 | Xenobiotica | pmid:22106961 |
Ogawa K et al. | A new approach to predicting human hepatic clearance of CYP3A4 substrates using monkey pharmacokinetic data. | 2013 | Xenobiotica | pmid:23153054 |
Lu XF et al. | Use of a semi-physiological pharmacokinetic model to investigate the influence of itraconazole on tacrolimus absorption, distribution and metabolism in mice. | 2017 | Xenobiotica | pmid:27533047 |
Zhu L et al. | Effects of CYP3A5 genotypes, ABCB1 C3435T and G2677T/A polymorphism on pharmacokinetics of Tacrolimus in Chinese adult liver transplant patients. | 2015 | Xenobiotica | pmid:25869250 |
Lampen A et al. | Catalytic activities, protein- and mRNA-expression of cytochrome P450 isoenzymes in intestinal cell lines. | 1998 | Xenobiotica | pmid:9622846 |
Jeong H and Chiou WL | Role of P-glycoprotein in the hepatic metabolism of tacrolimus. | 2006 | Xenobiotica | pmid:16507509 |
Patel CG et al. | Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus. | 2013 | Xenobiotica | pmid:22934787 |
Chitnis SD et al. | Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism. | 2013 | Xenobiotica | pmid:23278282 |
Miura M et al. | Comparison of enantioselective disposition of rabeprazole versus lansoprazole in renal-transplant recipients who are CYP2C19 extensive metabolizers. | 2005 | Xenobiotica | pmid:16012079 |
Niioka T et al. | Effects of CYP3A5 polymorphism and the tacrolimus 12 h concentration on tacrolimus-induced acute renal dysfunction in patients with lupus nephritis. | 2015 | Xenobiotica | pmid:26189776 |
Imamura R et al. | ABO-incompatible kidney transplantation with anti-CD20 monoclonal antibodies, intravenous immunoglobulin and plasmapheresis without splenectomy: a case report. | 2006 | Xenotransplantation | pmid:16623807 |
Song Z et al. | Tacrolimus inhibits discordant islet xenograft rejection: a study in the pig-to-rat model. | 2003 | Xenotransplantation | pmid:14617270 |
Balamurugan AN et al. | Effect of various immunosuppressive monotherapies on survival and histopathology of monkey islet xenografts in rats. | 2007 | Xenotransplantation | pmid:17669173 |
Miki T et al. | Hamster-to-rat bone marrow xenotransplantation and humoral graft vs. host disease. | 2001 | Xenotransplantation | pmid:11472629 |
Tachibana A et al. | Repopulation of the immunosuppressed retrorsine-treated infant rat liver with human hepatocytes. | 2013 Jul-Aug | Xenotransplantation | pmid:23683097 |
Li J et al. | [Regulatory effect of FK506 on the expression of CD152 and PD-1 in the liver allo-recipients]. | 2008 | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | pmid:18177621 |
He QH et al. | [The role of superantigen SEB-induced immunotolerance in the immune privileged site]. | 2003 | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | pmid:15132898 |
Bai YJ et al. | [Regulatory function of tacrolimus and CsA on CD4/CD8 T lymphocyte subgroups and costimulators on them in allo-liver recipients]. | 2008 | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | pmid:18845086 |
Pan ZX et al. | [IL-18 expression in whole blood cell cultures from active lupus nephritis and the inhibitory effects of FK506, cyclosporin A and dexamethasone]. | 2004 | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | pmid:15555450 |
Kagaya H et al. | Quantification and 24-hour monitoring of mycophenolic acid by high-performance liquid chromatography in Japanese renal transplant recipients. | 2006 | Yakugaku Zasshi | pmid:17139160 |
Tayama Y et al. | [Influence of tacrolimus and ciprofloxacin on glucose metabolism]. | 2007 | Yakugaku Zasshi | pmid:17978565 |
Naito T | [Optimal immunosuppressive therapy based on pharmacokinetics and pharmacodynamics of antimetabolites in clinical practice]. | 2010 | Yakugaku Zasshi | pmid:21139397 |
Yamaguchi K et al. | [Case of encephalopathy seemingly caused by tacrolimus at blood concentration near the upper limit of therapeutic range]. | 2012 | Yakugaku Zasshi | pmid:22790031 |
Nagao K et al. | [Drug development from natural fermentation products: establishing a manufacturing process which maximizes the potential of microorganisms]. | 2010 | Yakugaku Zasshi | pmid:21048405 |
Fukudo M | [Individualized dosage regimen of immunosuppressive drugs based on pharmacokinetic and pharmacodynamic analysis]. | 2007 | Yakugaku Zasshi | pmid:17603267 |
Sood S and Muthuraman A | Activity of tacrolimus: an immunosuppressant, in pyloric ligation-induced peptic ulcer in the rat. | 2009 | Yakugaku Zasshi | pmid:19952532 |
Tanaka H et al. | [Discovery and development of a novel immunosuppressant, tacrolimus hydrate]. | 1997 | Yakugaku Zasshi | pmid:9306728 |
Muraki Y | [Factors affecting the pharmacokinetics after living donor liver transplant]. | 2012 | Yakugaku Zasshi | pmid:23023417 |
Iwamoto T et al. | [Successful treatment by tacrolimus in two patients with Osserman's grade III intractable myasthenia gravis and elderly IIb]. | 2004 | Yakugaku Zasshi | pmid:15067188 |
Uchida K et al. | Pharmacokinetics of orally administered tacrolimus in lupus nephritis patients. | 2010 | Yakugaku Zasshi | pmid:20046074 |
Niwa T et al. | Effect of cyclosporine and tacrolimus on cytochrome p450 activities in human liver microsomes. | 2007 | Yakugaku Zasshi | pmid:17202802 |
Shimizu K | Development of New Liposome Targeting Strategies for Application of Disease Therapies. | 2017 | Yakugaku Zasshi | pmid:28049894 |
Tanaka Y et al. | [Effect of tacrolimus on the pharmacokinetics and glucuronidation of SN-38, an active metabolite of irinotecan]. | 2013 | Yakugaku Zasshi | pmid:23328499 |
Wang M et al. | Studies on the effects of the immunosuppressant FK-506 on the high-risk corneal graft rejection. | 2002 | Yan Ke Xue Bao | pmid:15510746 |
Li S et al. | Experiment study of retinal ultrastructure after intravitreal FK506. | 2004 | Yan Ke Xue Bao | pmid:15124532 |
Xie H et al. | Effect of topical FK506 used alone or combined with keratoplasty on patients with recurrent Mooren's corneal ulcer. | 2006 | Yan Ke Xue Bao | pmid:17378150 |
Ma H et al. | [The effect of FK506 on the proliferation of HRCECs]. | 2006 | Yan Ke Xue Bao | pmid:17378157 |
Zhang GM et al. | [Population pharmacokinetics of tacrolimus in Chinese renal transplant patients]. | 2008 | Yao Xue Xue Bao | pmid:18819472 |
Deng CH et al. | [The therapeutic drug monitoring network server of tacrolimus for Chinese renal transplant patients]. | 2011 | Yao Xue Xue Bao | pmid:22010353 |
Guan Z et al. | [Application of Fourier amplitude sensitivity test in Chinese healthy volunteer population pharmacokinetic model of tacrolimus]. | 2010 | Yao Xue Xue Bao | pmid:20931787 |
Xue L et al. | [Population pharmacokinetic study of tacrolimus in patients with hematopoietic stem cell transplant]. | 2009 | Yao Xue Xue Bao | pmid:20055140 |
Zhang YJ et al. | [Hypertrophy of the heart: calcineurin-NFAT pathway may be a new therapeutic target]. | 2006 | Yao Xue Xue Bao | pmid:17184105 |
Zhu L et al. | [Effect of CYP3A4*18B, CYP3A5*3 gene polymorphism on dosage and concentration of tacrolimus in renal transplant patients]. | 2012 | Yao Xue Xue Bao | pmid:22993851 |
Fu XH et al. | [Prediction of blood tacrolimus concentration in liver transplantation recipients by artificial neural network]. | 2012 | Yao Xue Xue Bao | pmid:23227541 |
Partaledis JA et al. | Saccharomyces cerevisiae contains a homolog of human FKBP-13, a membrane-associated FK506/rapamycin binding protein. | 1992 | Yeast | pmid:1279908 |
Oh CK et al. | Safety and efficacy of conversion from twice-daily tacrolimus to once-daily tacrolimus one month after transplantation: randomized controlled trial in adult renal transplantation. | 2014 | Yonsei Med. J. | pmid:25048494 |
Lee JH et al. | Withdrawal of immunosuppression in pediatric liver transplant recipients in Korea. | 2009 | Yonsei Med. J. | pmid:20046418 |
First MR and Fitzsimmons WE | Modified release tacrolimus. | 2004 | Yonsei Med. J. | pmid:15627307 |
Schwarz A | [Drug-induced kidney damage]. | 1996 | Z Arztl Fortbild (Jena) | pmid:8779233 |
Ocran KW et al. | Tacrolimus toxicity due to drug interaction with mibefradil in a patient after liver transplantation. | 1999 | Z Gastroenterol | pmid:10549098 |
Müller MK et al. | [Pathophysiologic concepts and protective possibilities in experimental pancreatic lesions]. | 1993 | Z Gastroenterol | pmid:7504856 |
Petrides AS | [Do immunosuppressive agents really impair glucose tolerance in liver transplant patients?]. | 1995 | Z Gastroenterol | pmid:7571761 |
Arnold JC and Theilmann L | [Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation]. | 1995 | Z Gastroenterol | pmid:7502559 |
Buechter M et al. | Tacrolimus as a reasonable alternative in a patient with steroid-dependent and thiopurine-refractory autoimmune pancreatitis with IgG4-associated cholangitis. | 2014 | Z Gastroenterol | pmid:24905108 |
Kanzler S et al. | Complete reversal of FK 506 induced diabetes in a liver transplant recipient by change of immunosuppression to cyclosporine A. | 1996 | Z Gastroenterol | pmid:8659188 |
Grube E et al. | Drug eluting stents: initial experiences. | 2002 | Z Kardiol | pmid:12641014 |
Scheller B et al. | Comparative study of tacrolimus and paclitaxel stent coating in the porcine coronary model. | 2005 | Z Kardiol | pmid:15997345 |
König A et al. | Intravascular ultrasound for assessment of coronary allograft vasculopathy. | 2000 | Z Kardiol | pmid:11151792 |
Weiner SM | [Combination of tacrolimus and MMF for treatment of proliferative lupus nephritis]. | 2016 | Z Rheumatol | pmid:27259912 |
Lütkes P et al. | [Quality of life following transplantation. The impact ofa new immunosuppressive substance]. | 1999 | Zentralbl Chir | pmid:10209841 |
David M et al. | [Changes in cervix cytology in women with liver transplants treated with immunosuppressive therapy]. | 1993 | Zentralbl Gynakol | pmid:7692689 |
Liu Y and Zheng M | [Suppression of Tacrolimus on the expression of MMP-9 in rhHGF-stimulated ECV304 cell line]. | 2004 | Zhejiang Da Xue Xue Bao Yi Xue Ban | pmid:15586415 |
Li Y et al. | [Effects of tacrolimus and cyclosporine on albumin secretion in cultured human hepatocyte]. | 2006 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | pmid:16859130 |
Peng LK et al. | [Slowing progression of chronic allograft nephropathy by conversion from cyclosporin A to tacrolimus]. | 2007 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | pmid:17344588 |
Li D et al. | [Effect of genetic polymorphism on disposition of calcineurin inhibitors in solid organ transplantation]. | 2010 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | pmid:20871172 |
Chiu MC | Management strategy for idiopathic nehprotic syndrome in children. | 2008 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | pmid:18245896 |
Sun Y et al. | [Total glucosides of peony as adjuvant therapy for prevention of cardiac allograft rejection in rats]. | 2007 | Zhong Xi Yi Jie He Xue Bao | pmid:17854565 |
Zhou Y et al. | [Effect of tacrolimus on growth-associated protein-43 expression in the hippocampus of neonatal rats with hypoxic-ischemic brain damage]. | 2009 | Zhongguo Dang Dai Er Ke Za Zhi | pmid:19149927 |
Huang WY | [Clinical application and side effects of immunosuppressant]. | 2007 | Zhongguo Dang Dai Er Ke Za Zhi | pmid:17448303 |
Li Y et al. | [Study on the Effect of Immunosuppressive Agent FK506 on Growth and Migration of Lung Cancer Cell]. | 2017 | Zhongguo Fei Ai Za Zhi | pmid:28738959 |
Li Q et al. | [Experimental study of electrophysiologic effects of regenerative nerve fibres affected by control releasing FK506]. | 2010 | Zhongguo Gu Shang | pmid:21254678 |
Yu HQ et al. | [Study of tacrolimus intranasal treatment for allergic asthma in mice]. | 2012 | Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi | pmid:23484272 |
Chen GF et al. | [Peripheral nerve regeneration under immunosuppression]. | 2002 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:11944523 |
Xiong G et al. | [Effects of immunosuppressants on proliferation of pheochromocytoma 12 and L929 cells]. | 2007 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:17694665 |
Kang H et al. | [Combined immunosuppression of FK506 and RS-61443 in rat limb allotransplantation]. | 2003 | Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi | pmid:12822367 |
Xie ZQ et al. | [Antipruritic mechanisms of pimecrolimus cream for facial dermatitis in adult women patients]. | 2009 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | pmid:19317053 |
Wen J et al. | [Regulatory effects of cyclosporin A and tacrolimus on the immunological gene expressions in renal transplant recipients]. | 2012 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | pmid:23286399 |
Tian T et al. | [Effect of tacrolimus on the growth cycle of murine hair follicles]. | 2007 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | pmid:17536270 |
Xie ZQ and Lan YZ | Effectiveness of pimecrolimus cream for women patients with sensitive skin and its underlying mechanism. | 2012 | Zhongguo Yi Xue Ke Xue Yuan Xue Bao | pmid:22954121 |
Gu HY et al. | [Significance of calcineurin activation and CD40L expression in patients with active lupus nephritis]. | 2005 | Zhongguo Ying Yong Sheng Li Xue Za Zhi | pmid:21162213 |
Xie SP et al. | [Study on the clinical application of wuzhi capsule after renal transplantation]. | 2011 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:22013798 |
Ding CG et al. | [Clinical application and exploration on mechanism of action of Cordyceps sinensis mycelia preparation for renal transplantation recipients]. | 2009 | Zhongguo Zhong Xi Yi Jie He Za Zhi | pmid:20329604 |
Nie F et al. | [Post-transplant kidney from C-III donation after cardiac death of children: a clinicopathologic study of 20 cases]. | 2016 | Zhonghua Bing Li Xue Za Zhi | pmid:26879429 |
Huang K et al. | [Prophylaxis and treatment of chronic graft versus host disease]. | 2005 | Zhonghua Er Ke Za Zhi | pmid:15833186 |
Zhou DJ and Wu XC | [Meta-analysis of calcineurin inhibitor in the treatment of lupus nephritis]. | 2011 | Zhonghua Er Ke Za Zhi | pmid:21624207 |
Wang ZL et al. | [Management of pediatric patients who underwent liver transplantation]. | 2007 | Zhonghua Er Ke Za Zhi | pmid:17880788 |
Wang HY et al. | [Clinical and pathological features of Denys-Drash syndrome: report of 3 cases]. | 2012 | Zhonghua Er Ke Za Zhi | pmid:23302619 |